Integrum AB INTEG B
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 54.60
- Day Range
- SEK 53.60–55.40
- 52-Week Range
- SEK 16.40–64.00
- Bid/Ask
- SEK 54.00 / SEK 54.60
- Market Cap
- SEK 1.01 Bil
- Volume/Avg
- 8,317 / 35,722
Key Statistics
- Price/Earnings (Normalized)
- 163.80
- Price/Sales
- 10.59
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 34
- Website
- http://www.integrum.se
Valuation
|
Metric
|
INTEG B
|
|---|---|
Price/Earnings (Normalized) | 163.80 |
Price/Book Value | 7.17 |
Price/Sales | 10.59 |
Price/Cash Flow | 599.28 |
Price/Earnings
INTEG B
Financial Strength
|
Metric
|
INTEG B
|
|---|---|
Quick Ratio | 3.04 |
Current Ratio | 4.09 |
Interest Coverage | — |
Quick Ratio
INTEG B
Profitability
|
Metric
|
INTEG B
|
|---|---|
Return on Assets (Normalized) | −2.59% |
Return on Equity (Normalized) | −2.98% |
Return on Invested Capital (Normalized) | −3.43% |
Return on Assets
INTEG B
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Fdbbbpgq | Pvcmvc | $181.1 Bil | |
SYK
| Stryker Corp | Ygjjflfbh | Tqgk | $127.5 Bil | |
MDT
| Medtronic PLC | Cnwggykv | Pkzhzc | $113.7 Bil | |
BSX
| Boston Scientific Corp | Gblgyszn | Gyyxl | $109.6 Bil | |
EW
| Edwards Lifesciences Corp | Qttsmxcl | Jbfsgs | $54.3 Bil | |
DXCM
| DexCom Inc | Sjwclwyyv | Qrs | $52.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Xpfqjvhpm | Nglzktv | $26.4 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Xbgrdjscpp | Cnnp | $24.7 Bil | |
ALGN
| Align Technology Inc | Lnstvps | Bgtqnny | $20.6 Bil | |
PODD
| Insulet Corp | Qlmkltkdc | Zkvgmf | $13.1 Bil |